Gene · 3597
Papers1,963
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 1,963
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The X in seX-biased immunity and autoimmune rheumatic disease. | J Exp Med | 2022 | 35510951 | PubTator, text mining | PubMed |
| The emerging roles of eosinophils: Implications for the targeted treatment of eosinophilic-associated inflammatory conditions. | Curr Res Immunol | 2022 | 35496822 | PubTator, text mining | PubMed |
| Neonatal Immune Responses to Respiratory Viruses. | Front Immunol | 2022 | 35493465 | PubTator, text mining | PubMed |
| Precision medicine in pediatric severe asthma: Targeted blockade of type 2 inflammation. | Cell Rep Med | 2022 | 35492881 | PubTator, text mining | PubMed |
| Nurr1 Modulation Mediates Neuroprotective Effects of Statins. | Adv Sci (Weinh) | 2022 | 35488520 | PubTator, text mining | PubMed |
| Signature transcriptome analysis of stage specific atherosclerotic plaques of patients. | BMC Med Genomics | 2022 | 35488341 | PubTator, text mining | PubMed |
| Recent Advances in IL-13Rα2-Directed Cancer Immunotherapy. | Front Immunol | 2022 | 35464460 | PubTator, text mining | PubMed |
| A Systematic Review of Atypical Endometriosis-Associated Biomarkers. | Int J Mol Sci | 2022 | 35457244 | PubTator, text mining | PubMed |
| Insights into Immune Escape During Tumor Evolution and Response to Immunotherapy Using a Rat Model of Breast Cancer. | Cancer Immunol Res | 2022 | 35446942 | PubTator, text mining | PubMed |
| Signaling Pathways That Mediate Alveolar Macrophage Activation by Surfactant Protein A and IL-4. | Front Immunol | 2022 | 35444643 | PubTator, text mining | PubMed |
| Interleukin-13 Receptor α1-Mediated Signaling Regulates Age-Associated/Autoimmune B Cell Expansion and Lupus Pathogenesis. | Arthritis Rheumatol | 2022 | 35438841 | PubTator, text mining | PubMed |
| Identification of Common and Distinct Pathways in Inflammatory Bowel Disease and Colorectal Cancer: A Hypothesis Based on Weighted Gene Co-Expression Network Analysis. | Front Genet | 2022 | 35432477 | PubTator, text mining | PubMed |
| The Obese Brain: Mechanisms of Systemic and Local Inflammation, and Interventions to Reverse the Cognitive Deficit. | Front Integr Neurosci | 2022 | 35422689 | PubTator, text mining | PubMed |
| Loss of Interleukin-13-Receptor-Alpha-1 Induces Apoptosis and Promotes EMT in Pancreatic Cancer. | Int J Mol Sci | 2022 | 35409019 | PubTator, text mining | PubMed |
| Update for Advance CAR-T Therapy in Solid Tumors, Clinical Application in Peritoneal Carcinomatosis From Colorectal Cancer and Future Prospects. | Front Immunol | 2022 | 35401510 | PubTator, text mining | PubMed |
| Antigen identification and high-throughput interaction mapping by reprogramming viral entry. | Nat Methods | 2022 | 35396484 | PubTator, text mining | PubMed |
| The use of amantadine in the prevention of progression and treatment of COVID-19 symptoms in patients infected with the SARS-CoV-2 virus (COV-PREVENT): Study rationale and design. | Contemp Clin Trials | 2022 | 35390511 | PubTator, text mining | PubMed |
| IL-4/IL-13 Axis in Allergic Rhinitis: Elevated Serum Cytokines Levels and Inverse Association With Tight Junction Molecules Expression. | Front Mol Biosci | 2022 | 35372516 | PubTator, text mining | PubMed |
| TP53 R273C Mutation Is Associated With Poor Prognosis in LGG Patients. | Front Genet | 2022 | 35368662 | PubTator, text mining | PubMed |
| A TMT-based shotgun proteomics uncovers overexpression of thrombospondin 1 as a contributor in pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome. | Arch Toxicol | 2022 | 35357534 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3597/papers?page=24